Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Lung scanner may predict breathing tube removal success

NCT ID NCT06876792

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a new way to predict if patients on breathing machines can safely have the tube removed. Researchers used a special imaging technique called electrical impedance tomography (EIT) to measure how well the lungs fill with air during a breathing trial. The goal was to see if this method could better predict who would need to go back on the machine within 48 hours, compared to standard tests. The study involved 150 adults with acute respiratory failure.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

150 people

The number who actually took part.

Started

Dec 2024

Finished

Dec 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

1. 150 critically ill patients requiring respiratory support were planned for inclusion 2. Age ≥18 years 3. Gender is not limited 4. Patients with expected duration of respiratory support \>24 hours

Ages

18 to 90 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age ≥18 years * Acute respiratory failure requiring intubation and mechanical ventilation ≥48 hours * Hemodynamic stability (no escalation of vasoactive agents) * Oxygenation: FiO₂ ≤0.5, PEEP ≤8 cmH₂O * Meeting standard ICU criteria for SBT readiness Exclusion Criteria: * Neuromuscular diseases impairing spontaneous breathing * High cervical spinal cord injury * Deep sedation (RASS ≤-3) * Inadequate EIT signal quality * Contraindications to EIT * Pregnancy * Expected survival \<24 h

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Acute respiratory failure are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Department of Critical Care Medicine,Ruijin Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai,China.

    Shanghai, 200025, China

  • Fujian Provincial Hospital

    Fuzhou, Fujian, 200025, China

  • Peking Union Medical College Hospital

    Beijing, Beijing Municipality, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.